Prenatal testing revenue in the third quarter of 2025 grew 2% year-over-year, reflecting ongoing expansion of payer coverage, particularly for Foresight Expanded Carrier Screen. Prenatal volume over ...

HLA class I alleles, one known and one newly identified, are linked to allopurinol-induced severe cutaneous adverse reactions ...

Opus Genetics has completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug ...

Atara Biotherapeutics (ATRA) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Now, a growing body of scientific evidence shows hundreds of genes act differently in the brains of biologically male or ...

Max Healthcare, one of the largest private sector healthcare services companies in India, and the Tata Institute for Genetics ...

Since 2023, the U.S. Food and Drug Administration (FDA) has not required animal testing, thanks in part to organoids, which ...

Fulgent Genetics, Inc. (FLGT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.24 per share. This compares to earnings of $0.31 per share a ...

Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -153.85% and +9.24%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...

Despite five heart attacks, multiple surgeries and a heart transplant, Cheney still lived a long life and died surrounded by ...

Genetic testing is transforming healthcare through personalized medicine, enabling early diagnosis, targeted treatments, and ...

To raise awareness about the health impact of diabetes-related misconceptions, Abbott launched the Above the Bias initiative.